- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05641168
A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Adhere to Abdominal and Peristomal Skin
August 27, 2025 updated by: Coloplast A/S
The study investigates different adhesive materials on healthy and peristomal skin
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Humlebæk, Denmark
- Coloplast Research Unit/Userlab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Has given written consent
- Be at least 18 years of age and have full legal capacity
- Have had a colostomy/ileostomy/urostomy for more than one year (for stoma patients) Have suitable peristomal skin area (assessed by investigator) (for stoma patients)
Exclusion Criteria:
- Currently receiving or have within the past 2 months received radio- and/or chemotherapy
- Currently receiving or have within the past month received topical steroid treatment in the abdominal skin area or systemic steroid (tablet/injection) treatment
- Are pregnant or breastfeeding
- Having dermatological problems in the abdominal area (assessed by investigator)
- Participate in other clinical investigations. Exception: Participation in other Coloplast sponsored clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ostomy Adhesive material
Newly designed ostomy adhesive material
|
Newly developed adhesive material
|
|
Other: comparator adhesive material
Adhesive material already on the market e.g adhesive material from SenSura Mio ostomy product
|
Standard adhesive material
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherent area
Time Frame: At every material change throughout the study, an average of 1 week
|
Adherent area (assessed by photos of adhesive materials)
|
At every material change throughout the study, an average of 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 28, 2021
Primary Completion (Actual)
May 30, 2024
Study Completion (Actual)
May 30, 2024
Study Registration Dates
First Submitted
November 15, 2022
First Submitted That Met QC Criteria
November 29, 2022
First Posted (Actual)
December 7, 2022
Study Record Updates
Last Update Posted (Estimated)
September 4, 2025
Last Update Submitted That Met QC Criteria
August 27, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP333
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Abnormalities
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Integrative Skin Science and ResearchArbonneCompleted
-
Hillel Yaffe Medical CenterUnknown
-
Avita MedicalBiomedical Advanced Research and Development AuthorityTerminatedSkin; DeformityUnited States
-
Let's DiscoCitruslabsCompletedSkin Abnormalities | AcneUnited States
-
Centre Hospitalier Departemental VendeeCompleted
-
HealthpointTerminatedSkin AbnormalitiesUnited States
Clinical Trials on Adhesive material
-
Doron KabiriRecruitingSurgical Site Infection (SSI)Israel
-
University of British ColumbiaChild and Family Research InstituteCompletedWounds and InjuriesCanada
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Ahmet KoçyiğitCompleted
-
GlaxoSmithKlineCompletedDenture RetentionUnited States
-
Coloplast A/SCompletedIleostomy - StomaDenmark
-
University Hospital, GenevaCompleted
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted